Morgan Stanley Thinks DraftKings Has Potential For Improving Parlay Mix & Hold

In this article:
  • Morgan Stanley analyst Stephen Grambling reiterated an Overweight rating on the shares of DraftKings Inc (NASDAQ: DKNG) and raised the price target from $20 to $22.

  • Meanwhile, the analyst removed the stock as Top Pick after an +80% move YTD (vs. +6% S&P 500, +28% gaming coverage).

  • DraftKings saw 11 states turn contribution profit positive this year and that should grow, said the analyst.

  • The company's parlay mix improved hold by ~70 bps y/y in FY22. Continued focus on parlays should drive even higher mix in the future and support structurally higher margins, added the analyst.

  • With DKNG moving closer to profitability, the analyst believes the company's NOL will start being ascribed value by the market.

  • The analyst raised estimates to reflect DKNG's 4Q beat, structurally better hold, and better cost control.

  • The new 2023 revenue estimate moves to $3.121 billion (versus $3.052 billion prior), which remains above the high end of guidance as the analyst anticipates stronger new state results and potential for further improvement in parlay mix & hold.

  • The analyst leans toward the high end of 2023 guidance and anticipates above consensus 2024 based on the state-by-state build.

  • Also ReadDraftKings 3.0: Analysts Raise Price Targets After Q4 Beat, Focus On Profitability

  • Price Action: DKNG shares are trading lower by 1.60% at $19.64 on the last check Wednesday.

Latest Ratings for DKNG

Date

Firm

Action

From

To

Mar 2022

Argus Research

Downgrades

Buy

Hold

Feb 2022

Citigroup

Maintains

Buy

Feb 2022

Roth Capital

Upgrades

Sell

Neutral

View More Analyst Ratings for DKNG

View the Latest Analyst Ratings

Don't miss real-time alerts on your stocks - join Benzinga Pro for free! Try the tool that will help you invest smarter, faster, and better.

This article Morgan Stanley Thinks DraftKings Has Potential For Improving Parlay Mix & Hold originally appeared on Benzinga.com

.

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Advertisement